Investors
in Precision Health
and Longevity
Our mission is to generate long-term value for our shareholders,
while making a positive impact on people’s quality of life.
We invest in disruptive entrepreneurs, technologies, and products
in the sectors of precision health and longevity.
Focused on return
on investment
Investment Strategy
Our approach is rooted in a new paradigm – evolving from reactive healthcare to predictive, preventive and personalized healthcare by leveraging big data, better lifestyles, tailored diet, and breakthrough treatments, as each individual’s health experience and longevity potential are unique.
We invest in companies with disruptive technologies, based on strong intellectual property, that can improve people’s longevity and quality of life, stemming from three distinct but overlapping areas: Biotechnology, Advanced Nutrition and Digital Health.
Biotechnology
The best science
changes lives.
Advanced nutrition
Companies shaping
the future of food.
Digital health
A strong enabler
of “Personalized health”.
Previous
Next
Founders
The founders of Precision Health Corp. are international executives and thought
leaders with deep banking, investment, and science expertise.
S. Catsicas
Founding investor and director
Stefan’s career spans the academic, corporate and entrepreneurial sectors. Former CTO and Executive Board member of Nestlé Global, he also served as Head of Neuroscience at the Glaxo Institute, as Chairman of Cell Biology at the School of Medicine of Lausanne, and as Vice-President Research at the Swiss Ecole Polytechnique Fédérale. He cofounded and advised biotechnology companies and large investment funds.J-P. Aoun
Founding investor
Jean-Pierre has more than twenty years’ experience in private banking and wealth management. Prior to co-Founding Crossbridge Capital, he was a Director at Credit Suisse, where he was a core member of a three-person team credited with building a significant wealth management portfolio, representing a major portion of the Middle East activity of the London office. Prior to joining Credit Suisse, Jean-Pierre was an Analyst at JP Morgan Private Bank.B. Collardi
Founding investor
How we invest
Early and late-stage private companies represent more than 80% of our assets.
We also consider crossover rounds, IPOs, listed companies and selected funds that have a specific thematic or geographical advantage and give us co-investment rights.
Understanding
biological diversity
Board of Directors
Precision Health Corp. is a protected cell company that is registered in the Isle of Man, a jurisdiction
which offers mature financial services with experienced, professional, legal and accounting infrastructure.
The regulatory environment is thorough and pragmatic with a tax-neutral environment for companies.
Stefan Catsicas
Stefan is a founder of Precision Health Corp. and acts as an executive director of the company. His
career spans the corporate, academic, and entrepreneurial sectors. Trained in neuroscience in
Switzerland and California, he served on the executive Boards of major academic institutions and
corporations, including the Lausanne School of Medicine, the Swiss Ecole Polytechnique Fédérale
and Nestlé Global.
Tim Shepherd
Tim is the managing director of Cains Advocates Limited and a director of Cains’ affiliated corporate and trust services provider. He was awarded a BSc in Economics and Accounting in 1992 and a LLM (Awarded with Distinction) in 1995, both from Bristol University. In 2008 Tim received the First Deemster’s Commendation (a discretionary award for those who truly excel in the Manx bar exams) and he became a public notary in the Isle of Man in 2016.
Tristan Head
Tristan is a director of Cains Advocates Limited and is also managing director of Cains’ affiliated corporate and trust services provider (Cains Corporate Services Limited). Tristan studied music and law at Cambridge University and was awarded a Master of Arts (MA) in 1997. Whilst at university, Tristan sang in the world-renowned Choir of King’s College Cambridge.
0
%
Year-on-year increase of VCinvestments in biotech & pharma
0
The number of ongoing clinicaltrials in the microbiome
$
0
B
The amount raised by digital healthstart-ups per quarter in 2021
Our portfolio in the three investment areas:
Biotechnology, Advanced Nutrition and Digital Health.
Berlin based, Infarm is growing the world’s largest global intelligent network of urban farms. Acting as “climate machines”, these farms have their own unique climate perfected for the crop they are hosting. Their industrial-scale modularity is the key differentiator behind their operations and expansion.
Based in Paris and Bologna, Five Seasons is a VC fund investing in food tech. From alternative proteins, to personalised nutrition, from natural ingredients to new models of food distribution, they back successful entrepreneurs throughout the food value chain.
Abintus Bio is a San Diego-based, preclinical stage gene therapy company focused on the discovery and development of a portfolio of first in-class, product candidates that are designed to directly reprogram immune cells.
Evox is an Oxford-based biotech company focused on harnessing and engineering the natural delivery capabilities of extracellular vesicles, known as exosomes that enable a wide variety of drugs to reach previously inaccessible tissues and compartments.
US, Cambridge-based Vedanta is advancing a new category of therapies based on rationally-defined immunoregulatory consortia of human microbiome-derived bacteria.
BE WTR, the Swiss water brand, is revolutionizing the international, premium water market with patented technologies and an unwavering commitment to sustainability, supporting 9 of the 17 UN SDGs and by being proud members of 1% for The Planet. In 2023 BE WTR was awarded the Red Dot “Best Product Design” and “Best Technology Innovation” at The Global Zenith Award
California-based One Bio is on a mission to revolutionize the field of fibers for health benefits. Applying a proprietary technology to convert natural fiber into simple, active fibers and prebiotics (oligosaccharides) that are soluble and palatable, they develop innovative applications for health and nutrition.
MaaT Pharma is a clinical stage oncology company located in Lyon (France) developing gut microbiome ecosystem restoration therapies to improve patients’ survival outcomes in life-threatening diseases such as acute myeloid leukemia and GvHD.
Cambridge-based, Tiba Biotech emanated from the MIT leveraging a revolutionary replicon RNA technology platform to develop safer, affordable vaccines for both human and animal health.
California-based, Infinant Health is an advanced nutrition company solving gut dysbiosis prevalent in newborn infants. Evolve platform delivers products that restore and maintain a healthy gut microbiome for preterm and term infants through hospital and consumer channels.
San Francisco-based Forward is a medical service redesigning the way healthcare is delivered by offering memberships that combine access to personal doctors with the latest technology (such as sensors, mobile, and AI).
Switzerland-based, Volumina Medical is a spin-off from the Swiss Federal Institute of Technology in Lausanne (EPFL) developing a platform of highly innovative biomaterials for regenerative medicine. Their platform of solutions addresses high unmet needs for the markets of reconstructive and plastic surgery. Their first target is the natural repair of the breast after cancer.
London-based, Compass Pathways (Nasdaq CMPS) is a life sciences company dedicated to developing new evidence-based therapies that will help patients suffering with mental illness and increase their wellbeing. Their first initiative is developing psilocybin for treatment-resistant depression.
Based in San Francisco, Cellares is shaping the future of cell therapy manufacturing and accelerating access to life-saving cell therapies. Its proprietary platform combines fully automated manufacturing and workflow customization.
Tropic Biosciences is a UK-based pioneering agricultural-biotech company dedicated to the development of high-performance varieties of tropical crops. Their innovative and proprietary gene-editing technology is first being applied to banana and coffee.
Switzerland-based AudioVitality is dedicated to maximizing the body’s potential at every life stage through cutting-edge, proprietary vibroacoustic technologies. Current applications include improving sports performance, effectively managing tinnitus, and enhancing overall well-being.
Foodberry developed patent-protected all-natural coatings inspired by the skin of a grape. These 100% plant-based skins act as protective barriers and deliver powerful taste and flavor profiles, enabling the creation of unique consumer health products.
Based in in Tel Aviv and Palo Alto, Ukko is a biotech company using cutting edge technologies in immunology, computational biology, and protein engineering to improve the lives of millions that suffer from food allergies and disorders.
Aleph Farms is an Israeli food tech and tissue engineering company that cultivates steaks from non-GMO cells without any harm to animals and with a significantly reduced impact to the environment.
Mirai Foods is a swiss cellular agriculture company, dedicated to providing delicious, high quality cultivated meat, at a fair price. Better for the planet and the animals, and healthier for people.
Please get in touch using our form. Your message will be dispatched
directly to us and we will answer you as soon as we can.